Skip to content

Evaluation of allergic reactions following COVID -19 vaccination in patients with documented allergies

Evaluation of allergic reactions following COVID -19 vaccination in patients with documented allergies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036490
Enrollment
255
Registered
2021-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T784- Other and unspecified allergy

Interventions

None listed

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusions are those with any allergic diatheses, including those with food and/or drug allergy and/ or history of anaphylaxis who had undergone thorough clinical evaluation and allergy testing.

Exclusion criteria

Exclusion criteria: Exclusions are patient less than 18 years of age, incomplete demographics and incomplete allergy testing data.

Design outcomes

Primary

MeasureTime frame
â?¢ Proportion of patients with history of drug or food allergy or history of anaphylaxis or combination, developing allergic reaction with COVID 19 vaccine. â?¢ Proportion of patients with documented allergic diathesis developing allergic reaction with either dose of COVID-19 vaccine. Timepoint: Baseline (Retrospective database study, data will be extracted at single time point)

Secondary

MeasureTime frame
â?¢ Proportion of patients with allergic diathesis who took the vaccine.Timepoint: Baseline (Retrospective database study, data will be extracted at single time point)

Countries

India

Contacts

Public ContactDr Nithya Gogtay

Seth G.S.M.C and K.E.M Hospital

njgogtay@hotmail.com9820495836

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026